Skip to content

Prospective naturalistic study on the effectiveness of alcohol withdrawal treatment taking into account individual impulsivity and aggressiveness

Prospective naturalistic study on the effectiveness of alcohol withdrawal treatment taking into account individual impulsivity and aggressiveness

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00034191
Enrollment
100
Registered
2024-05-03
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F10

Interventions

Group 1: Evaluation of the effectiveness of the qualified withdrawal therapy program (dt. qualifizierte Entgiftung
QE) established in the clinic followed by a 2-week (10 weekday sessions) intervention with repetitive transcranial magnetic stimulation (rTMS) with specific consideration and characterization of impul

Sponsors

Uniklinik RWTH Aachen; Klinik für Psychiatrie, Psychotherapie und Psychosomatik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: - Alcohol addiction disorder according to ICD-10 - AUDIT (Alcohol Use Disorders Identification Test) score >15

Exclusion criteria

Exclusion criteria: – Presence of acute suicidal behaviour or acute danger to others – Positive drug screening for illegal drugs (except cannabis) on admission (permitted on admission for inpatient treatment) – Presence of a relevant internal or neurological illness that could result in changes in cognition or personality traits – Limited or complete legal incapacity – Presence of a psychosis from the schizophrenic spectrum The following exclusion criteria apply to rTMS: – Diagnosis of genuine epilepsy or other confounding severe or unstable physical illness, dementia or cognitive impairment and history of traumatic brain injury – Existing pregnancy and breastfeeding – Presence of electromagnetically influenced or metal-containing medical devices in or permanently connected to the body (e.g. pacemakers, drug pumps, cochlear implants) – Previous operations on the heart and/or brain – Previous treatment with rTMS within the last 2 years – If metal parts are present in the body (e.g. screws after bone fracture, metal splinters, metal prostheses), TMS eligibility must be checked on a case-by-case basis

Design outcomes

Primary

MeasureTime frame
Outcomes are assessed at following timepoints: - Admission visit - V0 after physical detoxification (3rd day after the last administration of diazepam or clomethiazole) - V1 shortly before discharge (after the rTMS intervention; day 15 after the 1st rTMS session) - Follow-up visits 2/3 after 4/12 weeks after discharge 1. Abstinence parameter (visit 2/3) A Timeline-Follow-Back (TLFB) survey is used to determine the following main outcomes with regard to alcohol consumption: - Drinking-free days per time unit - Time until the first drink - Cumulative amount drunk (measured in standard drinks/time unit according to TLFB) - Number of days with more than 3 standard drinks/day 2. Aggression parameters (Viste 0) As part of the provocation paradigm (Point Subtraction Aggression Paradigm Variant I [reactive] / Variant II [proactive]), the relative proportions of aggressive monetary deductions from an opponent are calculated as an index of aggressive behavior. 3. biological parameters (admission visit, V0, V1) - BDNF in peripheral venous blood - Respiratory parameters

Secondary

MeasureTime frame
Secondary outcome parameters are: - Personality ratings and neuropsychological test parameters; recorded at V0 - Laboratory chemistry (transaminases, cholinesterase, ethyl glucuronide) and CDT (carbodeficient transferrin); recorded at the time of the admission visit, V0, V1

Countries

Germany

Contacts

Public ContactJana Hovancáková

Uniklinik RWTH Aachen; Klinik für Psychiatrie, Psychotherapie und Psychosomatik

jhovancakova@ukaachen.de+49 241 80-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026